首頁 > 市場調查報告書 > 製藥

臨床實驗

臨床試驗支援服務市場規模、佔有率和成長分析（按服務、階段、研究設計、適應症、申辦者和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1898503

臨床試驗支援服務市場規模、佔有率和成長分析（按服務、階段、研究設計、適應症、申辦者和地區分類）－2026-2033年產業預測

Clinical Trials Support Services Market Size, Share, and Growth Analysis, By Service (Administrative Staff, Clinical Trial Site Management), By Phase, By Study Design, By Indication, By Sponsor, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，臨床試驗支援服務市場規模將達到 248.4 億美元，到 2025 年將達到 268.3 億美元，到 2033 年將達到 496.6 億美元，預測期（2026-2033 年）的複合年成長率為 8%。

市場分析表明，臨床試驗支援服務在臨床試驗的成功開展和檢測設計中發揮著至關重要的作用。這些服務包括研究藥物的保管和儲存、臨床試驗中心管理、藥物劑量計算以及試劑盒管理監督等關鍵功能。新興市場慢性病、感染疾病和熱帶病的高發生率導致創新藥物需求激增，推動了該行業的快速成長。尤其值得一提的是，虛擬臨床試驗的普及應用已成為該行業收入成長的關鍵因素，它能夠幫助研究機構提高效率並簡化流程。此外，對病患招募和藥物盲法的日益重視也進一步凸顯了這些支持服務在推進臨床研究和滿足未被滿足的需求方面的重要性。

臨床試驗支援服務市場促進因素

臨床試驗支援服務市場的主要驅動力是感染疾病和慢性病發病率的上升趨勢，以及製藥公司大規模的研發投入。此外，受託研究機構（CRO）的興起也顯著促進了該行業的擴張。而且，對臨床試驗的需求不斷成長，尤其是在新興國家，這推動了對綜合支援服務的需求。這些因素共同為臨床試驗的成長創造了有利環境，體現了透過有效的調查方法方法不斷推進醫療保健解決方案和改善患者預後的努力。

臨床試驗支持服務市場的限制因素

臨床試驗支援服務市場的發展面臨許多挑戰，其中醫療基礎設施和先進技術資源的匱乏尤為突出。此外，嚴格的病患招募規定和缺乏高效的試驗管理系統也是限制該產業發展的主要障礙。然而，臨床試驗日益全球化，以及由研發驅動的持續技術創新，正為市場發展創造充滿希望的機會。克服這些限制將釋放新的潛力，為臨床試驗支援服務的未來發展奠定堅實的基礎，並促進業界更有效率的合作與協作。

臨床試驗支援服務市場趨勢

臨床試驗支援服務市場正經歷顯著成長，這主要得益於新興國家對臨床試驗需求的不斷成長以及製藥公司研發投入的增加。隨著專利到期給產業帶來挑戰，將臨床試驗外包給受託研究機構（CRO）的趨勢日益明顯，CRO的數量也不斷增加以滿足市場需求。這一趨勢反映了製藥業的策略轉變，企業在研發過程中更加重視效率和成本效益，進一步加劇了全球臨床試驗服務市場的競爭。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Laboratory Corporation of America Holdings（LabCorp）（USA）
Charles River Laboratories International, Inc.（USA）
Syneos Health, Inc.（USA）
Parexel International Corporation（USA）
ICON plc（Ireland）
Wuxi AppTec Co., Ltd.（China）
Eurofins Scientific（Luxembourg）
ACM Global Laboratories（USA）
Clinipace Worldwide（USA）
Worldwide Clinical Trials（USA）
Premier Research（USA）
PSI CRO AG（Switzerland）
Novotech（Australia）
Velocity Clinical Research（USA）
Fortrea（USA）
CTI Clinical Trial and Consulting Services（USA）

結論與建議

簡介目錄

Product Code: SQMIG35D2068

Clinical Trials Support Services Market size was valued at USD 24.84 Billion in 2024 and is poised to grow from USD 26.83 Billion in 2025 to USD 49.66 Billion by 2033, growing at a CAGR of 8% during the forecast period (2026-2033).

Market insights indicate that clinical trials support services play a crucial role in the successful execution of clinical testing and assay design. These services encompass essential functions such as securing and storing research medications, managing clinical trial sites, calculating drug dosages, and overseeing kit management. The industry has seen a surge in demand for innovative pharmaceuticals, driven by the prevalence of chronic, infectious, and tropical diseases in emerging markets. Notably, the adoption of virtual clinical trials has emerged as a key factor in the sector's revenue growth, enabling research firms to enhance efficiency and streamline processes. Increased focus on patient recruitment and drug blinding further underscores the importance of these support services in advancing clinical research and meeting unmet therapeutic needs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Clinical Trials Support Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Clinical Trials Support Services Market Segments Analysis

Global Clinical Trials Support Services Market is segmented by Service, Phase, Study Design, Indication, Sponsor and region. Based on Service, the market is segmented into Administrative Staff, Clinical Trial Site Management, Data Management and Institutional Review Boards. Based on Phase, the market is segmented into Phase I, Phase II, Phase III and Phase IV. Based on Study Design, the market is segmented into Expanded Access, Interventional and Observational. Based on Indication, the market is segmented into Autoimmune or Inflammation, Cardiovascular, Diabetes and Oncology. Based on Sponsor, the market is segmented into Medical Devices and Pharmaceutical & Biopharmaceutical. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Clinical Trials Support Services Market

The Clinical Trials Support Services market is primarily propelled by the increasing prevalence of infectious and chronic diseases, along with substantial research and development investments made by pharmaceutical companies. Additionally, the rise of contract research organizations has significantly contributed to this sector's expansion. Furthermore, there is a growing demand for clinical trials, especially in emerging nations, which enhances the need for comprehensive support services. These factors collectively create a robust environment for the growth of clinical trials, reflecting the ongoing commitment to advancing healthcare solutions and improving patient outcomes through effective research methodologies.

Restraints in the Clinical Trials Support Services Market

The growth of the Clinical Trials Support Services market faces challenges due to insufficient medical infrastructure and advanced technological resources. Furthermore, strict regulations concerning patient recruitment and the lack of efficient systems for trial management pose substantial barriers to the sector's development. However, the increasing globalization of clinical trials combined with ongoing technological innovations driven by research and development presents promising opportunities for market advancement. Addressing these constraints could unlock new potential and facilitate a more robust future for clinical trial support services, allowing for enhanced collaboration and efficiency in the industry.

Market Trends of the Clinical Trials Support Services Market

The Clinical Trials Support Services market is experiencing significant growth driven by increasing demand for trials in emerging economies, bolstered by heightened research and development investments from pharmaceutical companies. As the industry faces challenges from patent expirations, there is a shift towards outsourcing these trials to contract research organizations (CROs), which are proliferating in number to meet the demand. This trend reflects a strategic pivot in the pharmaceutical sector, where companies prioritize efficiency and cost-effectiveness in their R&D processes, further fueling the competitive landscape of clinical trial services on a global scale.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Clinical Trials Support Services Market Size by Service & CAGR (2026-2033)

Market Overview
Administrative Staff
Clinical Trial Site Management
- Patient Recruitment & Registry Services
- Patient Recruitment Management
- Patient Retention
Data Management
Institutional Review Boards

Global Clinical Trials Support Services Market Size by Phase & CAGR (2026-2033)

Market Overview
Phase I
Phase II
Phase III
Phase IV

Global Clinical Trials Support Services Market Size by Study Design & CAGR (2026-2033)

Market Overview
Expanded Access
Interventional
Observational

Global Clinical Trials Support Services Market Size by Indication & CAGR (2026-2033)

Market Overview
Autoimmune or Inflammation
Cardiovascular
Diabetes
Oncology

Global Clinical Trials Support Services Market Size by Sponsor & CAGR (2026-2033)

Market Overview
Medical Devices
Pharmaceutical & Biopharmaceutical

Global Clinical Trials Support Services Market Size & CAGR (2026-2033)

North America (Service, Phase, Study Design, Indication, Sponsor)
- US
- Canada
Europe (Service, Phase, Study Design, Indication, Sponsor)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Service, Phase, Study Design, Indication, Sponsor)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Service, Phase, Study Design, Indication, Sponsor)
- Brazil
- Rest of Latin America
Middle East & Africa (Service, Phase, Study Design, Indication, Sponsor)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Laboratory Corporation of America Holdings (LabCorp) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syneos Health, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Parexel International Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wuxi AppTec Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACM Global Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clinipace Worldwide (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Worldwide Clinical Trials (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Premier Research (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PSI CRO AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novotech (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Velocity Clinical Research (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fortrea (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CTI Clinical Trial and Consulting Services (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments